Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

NCT00603902 ·Status: COMPLETED ·Phase: PHASE3

To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake

NCT00829140 ·Status: COMPLETED ·Phase: PHASE1

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

NCT00395135 ·Status: COMPLETED ·Phase: PHASE3

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

NCT02022956 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

NCT01146522 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity

NCT04621227 ·Status: COMPLETED ·Phase: PHASE1

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

NCT00603291 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test Different Doses of BI 456906 in Patients With Obesity

NCT03591718 ·Status: COMPLETED ·Phase: PHASE1

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

NCT07310901 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

NCT06942923 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

NCT04686994 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications

NCT07012317 ·Status: COMPLETED ·Phase: NA

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

NCT01133210 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity

NCT06352437 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

NCT00978393 ·Status: COMPLETED ·Phase: PHASE1

Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

NCT02235961 ·Status: COMPLETED ·Phase: PHASE1

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

NCT01511185 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

NCT01511159 ·Status: COMPLETED ·Phase: PHASE1